What is the onset time of Ativan (lorazepam)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ativan (Lorazepam) Onset Time

Intravenous lorazepam begins working within 1-2 minutes, while intramuscular administration takes 15-20 minutes to onset, and oral administration requires 20-30 minutes before effects begin. 1, 2, 3

Route-Specific Onset Times

Intravenous Administration

  • Initial clinical effects begin within 1-2 minutes of IV push, though this represents the very beginning of drug action rather than peak sedation 1, 3
  • Peak sedative effects occur at 15-20 minutes after IV injection, when lack of recall and recognition are optimum 3
  • Administer over approximately 2 minutes (not rapid IV push) to minimize injection site pain 1

Intramuscular Administration

  • Onset occurs at 15-20 minutes after IM injection 4, 2, 3
  • Peak effects occur at approximately 60-90 minutes post-injection 2
  • Absorption is complete and rapid, with peak plasma concentrations reached within 3 hours 3
  • Duration of effect is 6-8 hours 4, 2, 3

Oral Administration

  • Onset time is 20-30 minutes after ingestion 2
  • Peak effects occur at approximately 2 hours after oral administration 2
  • Effective plasma concentrations are obtained within 30-60 minutes and maintained for 4-6 hours 5

Critical Safety Considerations During Onset Period

Respiratory Monitoring

  • Respiratory depression is the major adverse effect and may occur even at therapeutic doses, particularly when combined with opioids 1, 4
  • Continuous monitoring for respiratory depression is required during the onset period and throughout the duration of effect 1
  • Respiratory support equipment must be immediately available when administering IV lorazepam 1
  • The synergistic effect with opioids requires dose reduction and heightened vigilance 1, 4

Cardiovascular Effects

  • Hypotension may occur, especially in hemodynamically unstable patients or when combined with other CNS depressants 4
  • Elderly patients and those with baseline cardiovascular instability are at higher risk 4

Paradoxical Reactions

  • Approximately 10% of patients may experience paradoxical agitation rather than sedation 1
  • This occurs more frequently in younger patients and those with developmental disabilities 2, 1
  • Behavioral disinhibition may manifest instead of expected sedation 2

Comparison with Other Benzodiazepines

Midazolam has a faster onset (1-2 minutes IV with peak at 3-4 minutes) but much shorter duration (15-80 minutes) compared to lorazepam's longer-lasting effects 1, 4

Extended Monitoring Requirements

  • Extended monitoring is essential even after apparent recovery due to the elimination half-life of approximately 12 hours 1, 6
  • Sufficient drug remains after 24 hours to suggest residual CNS effects may still be present 5
  • In rare instances with doses exceeding recommendations, excessive sleepiness and prolonged lack of recall were noted beyond 24 hours 3
  • Unsteadiness and enhanced sensitivity to CNS-depressant effects of alcohol and other drugs were noted in isolated cases for greater than 24 hours 3

Special Population Considerations

Elderly Patients

  • Significantly more sensitive to sedative effects of benzodiazepines 4
  • Clearance is reduced, potentially prolonging onset-to-peak time and duration 4, 6

Hepatic Dysfunction

  • Benzodiazepine clearance is reduced, which may affect the duration but not necessarily the onset time 4, 6

Renal Failure

  • Elimination half-life is increased, prolonging duration of effect 4, 6
  • Active metabolites may accumulate with prolonged administration 4

References

Guideline

Onset of Action for IV Lorazepam

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Onset of Action for Intramuscular Lorazepam

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Lorazepam Clearance and Metabolism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.